Pharmaceutical cancer care for haematology patients on oral anticancer drugs: Findings from an economic, clinical and organisational analysis.
blood cancers
economic
leukaemia
lymphoma
myeloma
pharmacist
Journal
European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
revised:
26
09
2022
received:
27
07
2022
accepted:
09
10
2022
pubmed:
24
10
2022
medline:
30
11
2022
entrez:
23
10
2022
Statut:
ppublish
Résumé
The clinical benefit of pharmaceutical cares in improving the quality-of-care outcomes is well demonstrated. Clinical pharmacy services are not systematically deployed in cancer units in the absence of economic data. The aim of this prospective, observational 1-year study was to evaluate the clinical, economic and organisational impacts of pharmaceutical care into a multidisciplinary day hospital for patients treated with oral cancer drugs. All pharmacists' interventions (PI) were documented and their impact and the probability of adverse drug events were assessed using the clinical, economic and organisational tool. Among 360 admissions, an average of 1.81 PI per admission was accepted. Among 452 PI leading to a clinical benefit on the patient, 16.9% had a major impact, and 1.9% had an impact on survival. The large majority of PIs (87%) increased the quality-of-care organisation. The budget impact model showed a total cost savings and cost avoidance of €539,047 per year and a cost-benefit ratio of 7.07:1. The direct cost-benefit was €201,741, and the cost avoidance was €337,306. Multidisciplinary care and pharmaceutical care are key elements to improve cancer patients' outcomes and avoid evitable healthcare costs.
Substances chimiques
Antineoplastic Agents
0
Pharmaceutical Preparations
0
Types de publication
Observational Study
Journal Article
Langues
eng
Pagination
e13753Informations de copyright
© 2022 John Wiley & Sons Ltd.
Références
Allenet, B., Bedouch, P., Rose, F.-X., Escofier, L., Roubille, R., Charpiat, B., Juste, M., & Conort, O. (2006). Validation of an instrument for the documentation of clinical pharmacists' interventions. Pharmacy World & Science, 28, 181-188. https://doi.org/10.1007/s11096-006-9027-5
Bates, D. W., Spell, N., Cullen, D. J., Burdick, E., Laird, N., Petersen, L. A., Small, S. D., Sweitzer, B. J., & Leape, L. L. (1997). The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA, 277, 307-311. https://doi.org/10.1001/jama.1997.03540280045032
Baudouin, A., Herledan, C., Poletto, N., Guillemin, M.-D., Maison, O., Garreau, R., Chillotti, L., Parat, S., Ranchon, F., & Rioufol, C. (2021). Economic impact of clinical pharmaceutical activities in hospital wards: A systematic review. Research in Social & Administrative Pharmacy, 17, 497-505. https://doi.org/10.1016/j.sapharm.2020.07.016
Bedouch, P., Sylvoz, N., Charpiat, B., Juste, M., Roubille, R., Rose, F.-X., Bosson, J.-L., Conort, O., Allenet, B., & French Society of Clinical Pharmacy's Act-IP© Group. (2015). Trends in pharmacists' medication order review in French hospitals from 2006 to 2009: Analysis of pharmacists' interventions from the Act-IP© website observatory. Journal of Clinical Pharmacy and Therapeutics, 40, 32-40. https://doi.org/10.1111/jcpt.12214
Chan, A., Soh, D., Ko, Y., Huang, Y.-C., & Chiang, J. (2014). Characteristics of unplanned hospital admissions due to drug-related problems in cancer patients. Supportive Care in Cancer, 22, 1875-1881. https://doi.org/10.1007/s00520-014-2160-0
Conort, O., Bedouch, P., Juste, M., Augereau, L., Charpiat, B., Roubille, R., & Allenet, B. (2004). Validation of a coding tool for clinical pharmacy interventions. Journal de Pharmacie Clinique, 23, 141-147.
Escudero-Vilaplana, V., Ribed, A., Romero-Jimenez, R. M., Herranz-Alonso, A., & Sanjurjo-Saez, M. (2017). Pharmacotherapy follow-up of key points in the safety of oral antineoplastic agents. European Journal of Cancer Care, 26, e12463. https://doi.org/10.1111/ecc.12463
Gallagher, J., McCarthy, S., & Byrne, S. (2014). Economic evaluations of clinical pharmacist interventions on hospital inpatients: A systematic review of recent literature. International Journal of Clinical Pharmacy, 36, 1101-1114. https://doi.org/10.1007/s11096-014-0008-9
Girre, V., Arkoub, H., Puts, M. T. E., Vantelon, C., Blanchard, F., Droz, J. P., & Mignot, L. (2011). Potential drug interactions in elderly cancer patients. Critical Reviews in Oncology/Hematology, 78, 220-226. https://doi.org/10.1016/j.critrevonc.2010.05.004
Hoonhout, L. H. F., de Bruijne, M. C., Wagner, C., Asscheman, H., van der Wal, G., & van Tulder, M. W. (2010). Nature, occurrence and consequences of medication-related adverse events during hospitalization. Drug Safety, 33, 853-864. https://doi.org/10.2165/11536800-000000000-00000
Kopp, B. J., Mrsan, M., Erstad, B. L., & Duby, J. J. (2007). Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. American Journal of Health-System Pharmacy, 64, 2483-2487. https://doi.org/10.2146/ajhp060674
Laurent, V., Saillard, J., Thierry, M., Lepelletier, A., Fronteau, C., & Huon, J.-F. (2021). Anticancer agents and phytotherapy: Interactions that are often unrecognized. Journal of Oncology Pharmacy Practice, 27, 322-328. https://doi.org/10.1177/1078155220920363
Maggiore, R. J., Dale, W., Gross, C. P., Feng, T., Tew, W. P., Mohile, S. G., Owusu, C., Klepin, H. D., Lichtman, S. M., Gajra, A., Ramani, R., Katheria, V., Zavala, L., Hurria, A., & Cancer and Aging Research Group. (2014). Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: Effect on chemotherapy-related toxicity and hospitalization during treatment. Journal of the American Geriatrics Society, 62, 1505-1512. https://doi.org/10.1111/jgs.12942
Molassiotis, A., Brearley, S., Saunders, M., Craven, O., Wardley, A., Farrell, C., Swindell, R., Todd, C., & Luker, K. (2009). Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: A randomized, controlled trial. Journal of Clinical Oncology, 27, 6191-6198. https://doi.org/10.1200/JCO.2008.20.6755
Nazer, L. H., & Tuffaha, H. (2017). Health care and pharmacy practice in Jordan. The Canadian Journal of Hospital Pharmacy, 70, 150-155. https://doi.org/10.4212/cjhp.v70i2.1649
NCC MERP. (2014). National coordination council for medication error reporting and prevention index of medication errors [text]. Retrieved from https://www.nccmerp.org/types-medication-errors
Nerich, V., Limat, S., Demarchi, M., Borg, C., Rohrlich, P. S., Deconinck, E., Westeel, V., Villanueva, C., Woronoff-Lemsi, M. C., & Pivot, X. (2010). Computerized physician order entry of injectable antineoplastic drugs: An epidemiologic study of prescribing medication errors. International Journal of Medical Informatics, 79, 699-706. https://doi.org/10.1016/j.ijmedinf.2010.07.003
Nesbit, T. W., Shermock, K. M., Bobek, M. B., Capozzi, D. L., Flores, P. A., Leonard, M. C., Long, J. K., Militello, M. A., White, D. A., Barone, L. D., Goldman, M. P., & Kvancz, D. A. (2001). Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model. American Journal of Health-System Pharmacy, 58, 784-790. https://doi.org/10.1093/ajhp/58.9.784
Neuss, M. N., Polovich, M., McNiff, K., Esper, P., Gilmore, T. R., LeFebvre, K. B., Schulmeister, L., & Jacobson, J. O. (2013). 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. Journal of Oncology Practice, 9, 5s-13s. https://doi.org/10.1200/JOP.2013.000874
Neville, H. L., Chevalier, B., Daley, C., Nodwell, L., Harding, C., Hiltz, A., MacDonald, T., Skedgel, C., MacKinnon, N. J., & Slayter, K. (2014). Clinical benefits and economic impact of post-surgical care provided by pharmacists in a Canadian hospital. The International Journal of Pharmacy Practice, 22, 216-222. https://doi.org/10.1111/ijpp.12058
Nightingale, G., Hajjar, E., Swartz, K., Andrel-Sendecki, J., & Chapman, A. (2015). Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer. Journal of Clinical Oncology, 33, 1453-1459. https://doi.org/10.1200/JCO.2014.58.7550
Pharmaceutical Care Network Europe. (2020). Classification for drug related problems V9.1 [text]. Retrieved from https://www.pcne.org/upload/files/417_PCNE_classification_V9-1_final.pdf
Prithviraj, G. K., Koroukian, S., Margevicius, S., Berger, N. A., Bagai, R., & Owusu, C. (2012). Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. Journal of Geriatric Oncology, 3, 228-237. https://doi.org/10.1016/j.jgo.2012.02.005
Renaudin, P., Coste, A., Audurier, Y., Berbis, J., Canovas, F., Jalabert, A., Castet-Nicolas, A., Mercier, G., Villiet, M., Dagneaux, L., & Breuker, C. (2021). Clinical, economic, and organizational impact of the clinical pharmacist in an orthopedic and trauma surgery department. Journal of Patient Safety, 17, e1507-e1513. https://doi.org/10.1097/PTS.0000000000000539
Research, studies, evaluation and statistics department of French Government. (2010). Serious adverse events in healthcare facilities: Frequency, avoidability and acceptability [text]. Retrieved from https://drees.solidarites-sante.gouv.fr/sites/default/files/2020-10/dss17.pdf
Ribed, A., Romero-Jiménez, R. M., Escudero-Vilaplana, V., Iglesias-Peinado, I., Herranz-Alonso, A., Codina, C., & Sanjurjo-Sáez, M. (2016). Pharmaceutical care program for onco-hematologic outpatients: Safety, efficiency and patient satisfaction. International Journal of Clinical Pharmacy, 38, 280-288. https://doi.org/10.1007/s11096-015-0235-8
Riechelmann, R. P., Tannock, I. F., Wang, L., Saad, E. D., Taback, N. A., & Krzyzanowska, M. K. (2007). Potential drug interactions and duplicate prescriptions among cancer patients. Journal of the National Cancer Institute, 99, 592-600. https://doi.org/10.1093/jnci/djk130
Segal, E. M., Bates, J., Fleszar, S. L., Holle, L. M., Kennerly-Shah, J., Rockey, M., & Jeffers, K. D. (2019). Demonstrating the value of the oncology pharmacist within the healthcare team. Journal of Oncology Pharmacy Practice, 25, 1945-1967. https://doi.org/10.1177/1078155219859424
Swerdlow, S., Campo, E., Harris, N., Jaffe, E., Pileri, S., Stein, H., & Thiele, J. (2017). WHO classification of tumours of haematopoietic and lymphoid tissues [text]. Retrieved from https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017
Van den Bemt, P. M., Egberts, T. C., de Jong-van den Berg, L. T., & Brouwers, J. R. (2000). Drug-related problems in hospitalised patients. Drug Safety, 22, 321-333. https://doi.org/10.2165/00002018-200022040-00005
Van Leeuwen, R. W. F., Brundel, D. H. S., Neef, C., van Gelder, T., Mathijssen, R. H. J., Burger, D. M., & Jansman, F. G. A. (2013). Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs. British Journal of Cancer, 108, 1071-1078. https://doi.org/10.1038/bjc.2013.48
Vantard, N., Ranchon, F., Schwiertz, V., Gourc, C., Gauthier, N., Guedat, M.-G., He, S., Kiouris, E., Alloux, C., You, B., Souquet, P.-J., Freyer, G., Salles, G., Trillet-Lenoir, V., & Rioufol, C. (2015). EPICC study: Evaluation of pharmaceutical intervention in cancer care. Journal of Clinical Pharmacy and Therapeutics, 40, 196-203. https://doi.org/10.1111/jcpt.12242
Vo, H. T., Charpiat, B., Chanoine, S., Juste, M., Roubille, R., Rose, F.-X., Conort, O., Allenet, B., Bedouch, P., & Working Group “Valorization of Pharmacist Interventions” of the French Society of Clinical Pharmacy. (2021). CLEO: A multidimensional tool to assess clinical, economic and organisational impacts of pharmacists' interventions. European Journal of Hospital Pharmacy: Science and Practice, 28, 193-200. https://doi.org/10.1136/ejhpharm-2020-002642
WHO. (2022). Anatomical therapeutic chemical (ATC) classification [text]. Retrieved from https://www.who.int/tools/atc-ddd-toolkit/atc-classification
Yeoh, T. T., Si, P., & Chew, L. (2013). The impact of medication therapy management in older oncology patients. Supportive Care in Cancer, 21, 1287-1293. https://doi.org/10.1007/s00520-012-1661-y
Yeoh, T. T., Tay, X. Y., Si, P., & Chew, L. (2015). Drug-related problems in elderly patients with cancer receiving outpatient chemotherapy. Journal of Geriatric Oncology, 6, 280-287. https://doi.org/10.1016/j.jgo.2015.05.001
Zerbit, J., Chevret, S., Bernard, S., Kroemer, M., Ablard, C., Harel, S., Brice, P., Madelaine, I., & Thieblemont, C. (2020). Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: An observational cohort study. Annals of Hematology, 99, 1615-1625. https://doi.org/10.1007/s00277-020-04045-y
Zerillo, J. A., Goldenberg, B. A., Kotecha, R. R., Tewari, A. K., Jacobson, J. O., & Krzyzanowska, M. K. (2017). Interventions to improve oral chemotherapy safety and quality: A systematic review. JAMA Oncology, 4, 105-117. https://doi.org/10.1001/jamaoncol.2017.0625